Patent News

MarketWatch.com: New competition took a bite out of J&J’s drug sales, but don’t expect the trend to dominate this earnings season

MarketWatch.com: New competition took a bite out of J&J’s drug sales, but don’t expect the trend to dominate this earnings season
Biosimilar drugs should pressure pharma’s most valuable products little by littleCompetition by a new type of drug has been “nibbling around the edges” of company earnings, one analyst said.

The article was originally posted on MarketWatch as MarketWatch.com: New competition took a bite out of J&J’s drug sales, but don’t expect the trend to dominate this earnings season. Each article is copyrighted to their original authors. We do not own any rights to the news or the content of the news.